Abiologics, Inc. is a privately held, early-stage biotechnology company on a mission to make biology better through an innovative therapeutic modality. We are pioneering the development of Synteins, a transformational class of macromolecular medicines unlocked by novel synthetic and computational technologies. Abiologics is actively seeking exceptional scientists who are passionate about driving therapeutic modality innovation in biotechnology. Abiologics was founded in Flagship Pioneering's venture creation engine, where companies such as Moderna Therapeutics (NASDAQ: MRNA) and Generate Biomedicines were conceived and created. Since Flagship's founding in 2000, the firm has originated and fostered the development of more than 100 scientific ventures resulting in more than 500 issued patents and more than 50 clinical trials for novel therapeutic agents. We are seeking a biochemist to design, develop, and execute biochemical and biophysical strategies that enable the discovery and optimization of Synteins. The ideal candidate brings hands-on expertise in assay development, primary and secondary biochemical screening, and orthogonal biophysical characterization to establish target engagement, binding kinetics/thermodynamics, and mechanism of action. This role is highly collaborative, partnering closely with medicinal chemistry, computational sciences, and pharmacology.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Entry Level
Industry
Securities, Commodity Contracts, and Other Financial Investments and Related Activities
Education Level
Ph.D. or professional degree
Number of Employees
251-500 employees